Enanta Pharmaceuticals, Inc. Share Price

Enanta Pharmaceuticals, Inc. Share Price

NASDAQ: ENTA | Micro Cap
$10.88
-$0.25 (-2.29%) Last updated on 30 Oct, 2026 | 22:46 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Enanta Pharmaceuticals, Inc. Stock Performance

Open
$11.07
Prev. Close
$11.13
Circuit Range
N/A
Day Range
$10.88 - $11.07
Year Range
$10.32 - $17.11
Volume
4,672
Average Traded
$10.96

Enanta Pharmaceuticals, Inc. Share Price Today

As of 30 October 2026, Enanta Pharmaceuticals, Inc.'s share price is $10.88. The stock opened at $11.07, compared to its previous close of $11.13. During today's trading session, Enanta Pharmaceuticals, Inc.'s share price traded between $10.88 and $11.07, with an average price of $10.98. Over the past 52 weeks, the stock has recorded a high of $17.11 and a low of $10.32. In terms of performance, Enanta Pharmaceuticals, Inc.'s share price has declined by 21.56% over the last six months and is down 0.37% on a year-on-year basis.

Enanta Pharmaceuticals, Inc. Share Price Chart

Line chart of the Enanta Pharmaceuticals, Inc. price trend over the selected period. The price fell overall, ranging from 10.76 to 11.16, ending at 10.88.
$10.88$11.07
L
Show Current Price
H

Enanta Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$232135.68
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.17
Revenue (TTM)
$65.32B
Return On Equity (TTM)
-62.56%
Profit Margin
-125.37%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-4.28%

Enanta Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$15.13$18.62$17.16$14.36
Net Profit-$18.70-$11.94-$13.09-$19.50
Net Profit Margin-123.60%-64.12%-76.28%-135.79%
Income ChangeN/A36.15%-9.63%-48.97%

Enanta Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$86.16$79.20$67.64$65.32
Net Profit-$121.76-$133.82-$116.05-$81.89
Net Profit Margin-141.32%-168.96%-171.57%-125.37%
Income ChangeN/A-9.90%13.28%29.44%

About Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Enanta Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$13.43
$10.88
-17.58%
Sep 2026
$13.34
$13.20
-4.21%
Aug 2026
$12.47
$13.78
+9.45%
Jul 2026
$14.83
$12.59
-13.50%
Jun 2026
$13.09
$14.55
+10.77%
May 2026
$13.92
$13.14
-5.26%
Apr 2026
$12.96
$13.87
+10.04%
Mar 2026
$14.14
$12.61
-11.17%
Feb 2026
$13.11
$14.19
+9.91%
Jan 2026
$15.35
$12.91
-18.63%
Dec 2025
$14.23
$15.87
+12.36%
Nov 2025
$11.03
$14.12
+29.30%

ENTA Share Price FAQs